Christopher Alafi, Director at Intra-Cellular Therapies, holds 5.74M shares in Intra-Cellular Therapies (Ticker: ITCI), holds 1.31M shares in Stereotaxis (Ticker: STXS).

See the Hottest Stocks Based on Insider Trading >

Christopher Alafi
Intra-Cellular Therapies (ITCI)
Director

Ranked #119 out of 98,743 Corporate Insiders

Profitable Transactions

14 out of 18 Profitable Transactions

Average Return

+93.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.27%

ITCI

0.73%

STXS

A breakdown of Christopher Alafi's holdings

See the Top Stocks by Insiders

Insider Roles

Intra-Cellular Therapies
(ITCI)

Director

Stereotaxis
(STXS)

Ten Percent Owner

Roles that Christopher Alafi holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Intra-Cellular Therapies
(ITCI)

Rating:Informative Buy

Date:Nov 28, 2014 - Nov 28, 2015

Return:+308.90%

The most profitable trade made by Christopher Alafi

See the Latest Stocks Traded by Insiders

Christopher Alafi's Trading History

ITCI

Intra-Cellular Therapies

May 25, 2021

Director

Uninformative Sell

1.12M

$384.36M

STXS

Stereotaxis

Aug 20, 2013

Ten Percent Owner

Informative Buy

877.77K

$2.82M

List of latest transactions for each holding click on a transaction to see Christopher Alafi's performance on stock

See All Insider Trading from Today

Christopher Alafi insider profile FAQ

What is the percentage of profitable transactions made by Christopher Alafi?

The percentage of profitable transactions made by Christopher Alafi is 78%.

What is the average return per transaction made by Christopher Alafi?

The average return per transaction made by Christopher Alafi is 93.10%.

What stocks does Christopher Alafi hold?

Christopher Alafi holds: ITCI, STXS stocks.

What was Christopher Alafi’s latest transaction?

Christopher Alafi latest transaction was an Uninformative Sell of $1.12M.

What was Christopher Alafi's most profitable transaction?

Christopher Alafi’s most profitable transaction was an Informative Buy of ITCI stock on November 28, 2014. The return on the trade was 308.90%.

What is Christopher Alafi's role in Intra-Cellular Therapies?

Christopher Alafi's role in Intra-Cellular Therapies is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Christopher Alafi Insider Profile

Christopher Alafi Intra-Cellular Therapies (ITCI)Director